Lung cancer mets to brain prognosis

A spread to the brain is called a brain metastasis. Outlook is not determined by the scan alone. Clinicians consider the number, size, and position of brain deposits, whether other organs are involved, the lung cancer subtype, genomic findings, symptoms, and how well a person can manage everyday activities. Newer targeted medicines, immunotherapy, chemotherapy, radiotherapy, and supportive treatments may be considered according to the individual diagnosis. A discussion about [Brain Metastases](/conditions/brain-metastases/) and [Lung Cancer](/conditions/lung-cancer/) can help put the scan into context.

Ask the oncology team to explain the brain imaging, whether tissue testing or [Genomic Tumour Profiling](/treatments/diagnostics-and-staging/genomic-tumour-profiling/) could guide treatment, and which goals matter most to you. Options may include focused or whole-brain [Radiotherapy](/treatments/radiation-oncology/radiotherapy/), medicines that reach cancer cells throughout the body, or surgery in selected situations. Steroids or anti-seizure treatment may be used for particular symptoms. [Palliative Care](/treatments/supportive-and-palliative-care/palliative-care/) can support comfort, function, mood, and family needs alongside cancer treatment.

Contact emergency services for a first seizure, a seizure that does not stop, sudden weakness on one side, new trouble speaking, severe confusion, loss of consciousness, or a rapidly worsening headache with vomiting. Report new balance problems, vision changes, personality changes, or increasing sleepiness promptly, because brain swelling or bleeding may need urgent assessment.

Which findings on my scan affect the outlook? What treatment is recommended for the brain and the lung cancer? Should genomic testing change the plan? How will we monitor symptoms and treatment response?